Thonburi Medical Centre Valuation
Is KDH-R undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of KDH-R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: KDH-R (THB92) is trading above our estimate of fair value (THB46.99)
Significantly Below Fair Value: KDH-R is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for KDH-R?
Other financial metrics that can be useful for relative valuation.
What is KDH-R's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ฿1.78b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1.1x |
Enterprise Value/EBITDA | 6.4x |
PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does KDH-R's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 19.7x | ||
AHC Aikchol Hospital | 14.6x | n/a | ฿2.4b |
NEW Wattana Karnpaet | 16.4x | n/a | ฿825.0m |
M-CHAI Mahachai Hospital | 26.8x | n/a | ฿5.1b |
TRP Aesthetic Connect | 21.1x | 19.3% | ฿3.3b |
KDH-R Thonburi Medical Centre | 14x | n/a | ฿1.8b |
Price-To-Earnings vs Peers: KDH-R is good value based on its Price-To-Earnings Ratio (14x) compared to the peer average (19.7x).
Price to Earnings Ratio vs Industry
How does KDH-R's PE Ratio compare vs other companies in the TH Healthcare Industry?
Price-To-Earnings vs Industry: KDH-R is good value based on its Price-To-Earnings Ratio (14x) compared to the TH Healthcare industry average (24.7x).
Price to Earnings Ratio vs Fair Ratio
What is KDH-R's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 14x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate KDH-R's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.